The intravenous regional anesthesia. Anaesthetics and therapeutic gases
Conditions
Interventions
Intervention 1: In the control group local anesthetic solution of 3miligeram per kilogeram body weight lidocaine with a concentration of 0.5percentage diluted with normal saline will injected via intr
Prevention
In the control group local anesthetic solution of 3miligeram per kilogeram body weight lidocaine with a concentration of 0.5percentage diluted with normal saline will injected via intravenous cannula
In the Intervention group local anesthetic of 3 miligeram per kilogeram body weight lidocaine with a concentration of 0.5percentage addition to 200 microgeram nitroglyserine injected via intravenous c
Sponsors
Vice Chancellor for research of Zahedan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: non urgent surgery; age more than 20 years. Exclusion criteria: Sickle cell anemia; Raynaud's phenomena; history of use of nitroglycerine; history of use of sildenafil in 24 hours ago; history of allergy.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patient's tourniquet pain. Timepoint: At 5, 10, 15, 20, 40 minutes after the start of operation will be evaluated. Method of measurement: According to VAS score.;Venous oxygen saturation. Timepoint: Before and after use tourniquet. Method of measurement: By pulse oximetry based on mmHg. | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood Pressure. Timepoint: Before and after use tourniquet. Method of measurement: By mercury sphygmomanometer based on mmHg.;Heart Rate. Timepoint: Before and after use Tourniquet. Method of measurement: By pulse oximetry based on the number of minutes. | — |
Countries
Iran (Islamic Republic of)
Outcome results
None listed